The study found that there was increased expression of certain proteins, including transforming growth factor beta (TGF-β), bone morphogenetic protein 2 (BMP-2), and insulin-like growth factor 1 (IGF-1) in the bone tissues of melorheostosis patients compared to healthy controls [8]. This evidence concerns the gene BMP2 and melorheostosis.